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ABSTRACT 46 
 47 
 48 
Avian Metapneumovirus (AMPV) infection of poultry causes serious disease in most countries and 49 
subtype A reverse genetic (RG) systems have allowed generation of viruses of known sequence, 50 
and proved useful in developments towards better control by live vaccines.  While subtype B 51 
viruses are more prevalent, bacterial cloning issues made subtype B RG systems difficult to 52 
establish. A molecular comparison of subtype A and B viruses was undertaken to assess whether 53 
subtype A RG components could be partially or fully substituted. AMPV subtype A and B gene end 54 
sequences leading to polyadenylation  are reported for the first time,  as well as several leader and 55 
trailer sequences. After comparing these alongside previously reported gene starts and protein 56 
sequences, it was concluded that subtype B genome copies would be likely to be rescued by a 57 
subtype A support system, and this assertion was supported when individual subtype A components 58 
were successfully substituted. Application of an advanced cloning plasmid permitted eventual 59 
completion of a fully subtype B RG system, and proved that all subtype specific components could 60 
be freely exchanged between A and B systems.  61 
 62 
 63 
INTRODUCTION 64 
 65 
Avian rhinotracheitis is a major disease affecting domestic poultry throughout most of the world 66 
and is caused by infection with avian metapneumovirus (AMPV). Four AMPV subtypes (A to D) 67 
have been discovered and of these subtypes A and B are considered responsible for most AMPV 68 
related disease in chickens and turkeys outside of the USA. The extensive use of live vaccines of 69 
both A and B subtypes has made it difficult to accurately assess the relative prevalence of each 70 
subtype in the field in many world regions, but nonetheless subtype B field strains are generally 71 
accepted to be dominant in Western Europe, and for this reason, vaccination with this subtype has 72 
been prioritised (Cecchinato et al., 2014). 73 
 74 
For more than ten years, the availability of subtype A reverse genetics (RG) systems (Ling et al., 75 
2008; Naylor et al., 2004) has allowed subtype A virus genomes to be modified and the resultant 76 
phenotypes investigated. Within suitable cells, full length DNA viral copies, transcribed to RNA in 77 
the presence of a number of essential AMPV proteins, produce the remaining viral proteins, then 78 
viruses with sequences matching the genome copy. Using this RG tool, effects of some precise 79 
genetic changes on virus properties have been determined, in terms of gene deletions (Ling et al., 80 
2008; Naylor et al., 2004), virulence (Brown et al., 2011), protective capacity of live vaccines 81 
(Naylor et al., 2010) and gene insertions (Falchieri et al., 2013). 82 
 83 
Generally in mononegavirales reverse genetics systems, the viral polymerase replicates N protein 84 
encapsidated RNA antigenome in association with the P protein, and for the family Pneumovirus 85 
transcription factor M2 protein, as has been reviewed previously for similar viruses (Whelan et al., 86 
2004).  Specific genome sequences are known to be involved in regulation of polymerase 87 
attachment, genome replication, transcription initiation, transcription termination and the balance of 88 
genome and antigenome copies, but for AMPV most details of these sequences remain unknown.  89 
For genome replication, the viral polymerase must recognise replication signals but ignore 90 
transcription start/stop signals, whereas for transcription, these signals must be recognised.  91 
 92 
Comparison of complete genome sequences has shown that subgroups A, B and D are more related 93 
to each other than subtype C (Brown et al., 2014) and another comparison of subtypes A, B and C 94 
showed subtype A and B to have the most similar genomes (Jacobs et al., 2003). Subtypes A and B 95 
also appear to be most similar in their species specificity and behaviours in the field, hence live 96 
subtype A and B vaccines have been employed largely interchangeably to control disease in 97 
commercial turkeys and chickens, albeit with an increasing  bias toward subtype B. Cross protection 98 
and antigenic studies have suggested that some protective and antigenic differences do exist  99 
(Collins et al., 1993; Cook et al., 1993; Van de Zande et al., 2000) and this highlighted the need for 100 
a reverse genetics system to enable the generation of improved live subtype B vaccines, as well as 101 
to understand other properties of this subtype.  102 
 103 
A project to develop a subtype B reverse genetics system was initiated in our laboratory soon after 104 
the subtype A development (Naylor et al., 2004) but encountered problems. Also at a similar time 105 
other groups were known to have initiated similar ventures yet no system was forthcoming. In our 106 
case this was due to problems encountered while attempting to clone larger subtype B genome 107 
sections into the plasmids previously found successful for cloning subtype A viruses. While N, P 108 
and M2 genes could be readily cloned, the L gene and full genome proved impossible, as sequences 109 
proved toxic even using the specialist tolerant cloning bacteria previously found adequate for 110 
subtype A. This either led to the complete absence of clones, or clones containing major deletions, 111 
often of several thousand nucleotides. 112 
 113 
With a view to potentially utilising some of the available subtype A RG system components in the 114 
development of a subtype B system, it was decided to investigate properties of subtype A and B 115 
viruses likely to affect rescue and replication. Leader and trailer sequences essential for attachment 116 
of the viral polymerase were determined and compared, as were those sequences recognised by the 117 
viral polymerase in initiating and terminating the transcription of individual viral genes.  The study 118 
further compared protein similarities, especially for N, P, M2 and L which are all directly involved 119 
in encapsidation, replication and transcription of the genome in a reverse genetics system. In most 120 
cases we report for the first time the individual gene transcription stop signals for both subtype A 121 
and B virus genes, as well as many previously unreported leader and trailer sequences.  While many 122 
gene stop sequences were predictable from available genome sequences, others were not, especially 123 
where more than one termination like sequence was present at a gene end, as for example seen with 124 
the M2 and G genes. When combined, results of these studies suggested that subtype A and B 125 
reverse genetics systems might be able to recover full genome copies of the opposite subtype. Due 126 
to the importance of AMPV subtype C in North America and elsewhere, comparison included an 127 
established virus from that subtype.   128 
 129 
During the investigation cloning attempts were continued and during these, a literature search 130 
brought to our awareness a commercial plasmid pSMART that had permitted problematic regions 131 
of an influenza virus genome to be successfully cloned (Zhou et al., 2011). This was applied in 132 
cloning the subtype B full genome and L gene.  Finally a subtype B cloned genome was rescued 133 
with either subtype A or B support components, hence this study includes report of the first AMPV 134 
subtype B reverse genetics system. We also demonstrated the rescue of a subtype A virus using this 135 
subtype B reverse genetics system.  136 
.   137 
 138 
RESULTS  139 
 140 
Determination and comparison of leaders and trailer sequences 141 
 142 
Determined leader and trailer sequences are give in Table 1 and sequence chromatograms in Figure 143 
1.  For reference, leader and trailer sequences from a previously published subtype C virus are 144 
included in Table 1.  For subtypes A and B, leaders or trailers sequences were always found to be in 145 
agreement for viruses within the same subtype. 146 
 147 
The leader sequences of subtype A and B viruses were identical for the first 12 nucleotides and 148 
when compared to antigenomic trailer sequences, for subtype A they were identical for those first 149 
12 nucleotides, whereas differences were found for subtype B. After position 12 similarities became  150 
minimal.  151 
 152 
For the trailer, an antigenomic sequence from nucleotides 13-21 GGCAUAAGU was detected in all 153 
3 subtypes.   For all 3 subtypes the remaining 18-24 nucleotides of the leader/trailer sequences up to 154 
the N start/L end were mainly comprised of apparently random Us and As and there was no obvious 155 
common sequence motif between the subtypes.  156 
 157 
The 2 GGs normally assumed to be added to the virus leader due to use of a T7 promoter in RG 158 
derived viruses were never detected.  159 
 160 
Determination and comparison of gene start and stop sequences 161 
 162 
 163 
Determined mRNA sequence chromatograms for each gene are shown in Figure 2.  Gene start and 164 
stop sequences for subtype A and B viruses are compared in Table 2 in genome sense (3’to 5’) and 165 
include sequences predicted from a previously determined published subtype C virus full genome 166 
(accession number AY579780). All genes started with the sequence 3’CCCUGUUCA5’ with the 167 
exception of F and SH genes of subtype B which started with 3’CCCCGUUCA5’. All gene stop 168 
signals started with UCA then had a variable sequence of generally 3 to 5 nucleotides after which 169 
followed between four and seven Us (which became the polyA tail), with the exception of the 170 
subtype A SH gene which had an 11 nucleotide separation but which still efficiently stopped 171 
transcription and led to polyadenylation. In the case of Germany A virus, sequence changes within 172 
this 11 nucleotide region led to absence of detectable monocistronic SH mRNA. This absence of 173 
detectable SH gene transcription termination would be assumed to prevent downstream  G 174 
expression (Naylor et al., 2007; Whelan et al., 2004). Otherwise the subtype A and B transcription 175 
stop sequences were very similar as shown in Table 3 with a consensus for subtype A of  176 
UCAAU(A/U)A(A/U)UUUU and subtype B of  UCAAUAU(A/U)UUUU.  177 
 178 
Comparison of viral protein sequences  179 
 180 
Details of nucleotide identities, together with amino acid sequence identities and similarities for 181 
subtypes A, B and C are given for each gene in Table 4. Comparison of A, B and C sequences 182 
confirmed that subtype A and B proteins were more closely related to each other than they were to 183 
subtype C.  Between subtypes A and B, those proteins expressed from transfected cloned DNA in 184 
the reverse genetics system, N, P, M2 and L, had amino acid similarities of over 80%, and this was 185 
also the case for M and F. In contrast when comparing either subtypes A or B to subtype C, the 186 
similarity fell to approximately 79% in the case of the L gene. For the nonessential genes SH and G 187 
(Naylor et al., 2004), amino acid similarities between subtypes A and B were much lower at 60% 188 
and 46% respectively and fell to approximately half those values when SH and G of either subtype 189 
was compared to subtype C.  190 
 191 
Recovery of virus from AMPV full length copies 192 
 193 
Combinations of cloned genes and genomes from both A and B subtypes are given in table 5, which  194 
shows that all combinations of subtype A and B components led to virus rescue.  195 
 196 
 197 
DISCUSSION 198 
 199 
Comparison of subtype A and B amino acid sequences of those proteins required for the RG system, 200 
N, M2 and L, showed very high levels of amino acid identity and similarity while P had a lower 201 
identity yet maintained 88% similarity. The fusion and matrix proteins were also highly similar. 202 
While SH and G genes identities were much lower,  these genes are not required for virus 203 
replication in cell culture (Naylor et al., 2004) or turkeys (Naylor et al., 2010) so those differences 204 
were not considered an impediment to virus rescue.  The subtype C sequences were more different, 205 
having polymerase identities and similarities with subtype A and B viruses of 64% and 79% 206 
respectively. These data suggested that subtype A and B viruses might be recovered from subtype A 207 
or B full-length genome copies using either subtype A or B support proteins. It is not clear whether 208 
in spite of the greater differences found for the subtype C polymerase, subtype A and B reverse 209 
genetics components might still recover virus from subtype C full length copies.   210 
 211 
 212 
For similar viruses, the viral polymerase is known to recognise sequences in the leader and trailer 213 
which play a role in transcription, replication and genome encapsidation. (Whelan et al., 2004). The 214 
leader sequences of AMPV subtypes A, B  and C and antigenome trailer of subtype A were 215 
identical for the first 12 nucleotides, whereas subtype B and C trailers had a 2 nucleotide mismatch. 216 
Beyond nucleotide 12, virus leaders did not match their trailers and furthermore no common 217 
sequence motif was seen when comparing between subtypes. In contrast within the antigenome 218 
trailers of all three subtypes between nucleotides 13-21, a sequence of 3’GGCAUAAGU 5’ was 219 
found.  When later the NCBI database was searched for all available equivalent sequences 220 
( accession numbers HG934338 (subtype C, host duck ), FJ 977568 (subtype C, host turkey), 221 
AB548428 (subtype B, host chicken), AY 590688 (subtype C host turkey) ) this same sequence was 222 
always detected. While this sequence might be coincidental, it might also have some regulation role, 223 
perhaps in the replication of the antigenome copy in subtype A, B and C viruses.  However further 224 
RG based studies would be required to substantiate such a hypotheses. But whatever the specific 225 
role of the sequence, or the extreme 12 nucleotides of the leaders and trailer, the similarity across 226 
subtypes would appear compatible with the notion of a subtype independent RG system.   227 
 228 
Interestingly, while the use of a T7 promoter in the RG system would be expected to add two GG 229 
residues to the start of the antigenome copy which would be expected to be incorporated into the 230 
genome, and have sometimes been suspected of causing phenotypic differences between 231 
recombinant and original virus from which the DNA copy has been prepared, these were never 232 
detected.  We therefore conclude that these are edited out at an early stage of the RG rescue. This is 233 
a helpful practical observation because while the T7 promoter is very useful in RG systems, it is 234 
sometime avoided because of this perceived implicit sequence addition. 235 
 236 
A previously comprehensive minigenome investigation of gene start signal efficiencies showed that 237 
the CCCUGUUCA was most efficient and that the variant sequence of CCCCGUUCA found on 238 
subtype B SH and G proteins would be expected to reduce transcription of those genes (Edworthy 239 
& Easton, 2005). The L gene transcription start sequences  proved an exception and minigenome 240 
studies showed a reduced transcription efficiency (Edworthy & Easton, 2005), as might be expected 241 
for a gene coding a protein needed in smaller amounts.  Surprisingly gene starts of the otherwise 242 
more distantly related subtype C viruses (Brown et al., 2014) like the subtype A viruses all used 243 
CCCUGUUCA, but again with the exception of the L gene. Clearly lack of gene start differences 244 
would means that gene start differences would not preclude a subtype independent RG system for 245 
AMPV. 246 
 247 
Transcription stop sequences had not been previously reported for most AMPV genes. In general 248 
the sequences found for AMPV subtype A and B were in agreement with those found previously for 249 
respiratory syncytial virus (Harmon et al., 2001). Nonetheless, a study of seven recombinant 250 
subtype A viruses, each containing a GFP reporter gene at different intergenic regions had shown 251 
that GFP expression did not follow the accepted model and suggested that inefficient genome stop 252 
sequences  may have been playing a role (Falchieri, 2012), as had already been found to affect 253 
protection induced by candidate vaccines only differing in the their SH gene ends (Naylor et al., 254 
2007).  Similarly in the current study it proved impossible to detect monocistronic SH mRNA in a 255 
German field strain which implies that the downstream G gene would be unlikely to be expressed,  256 
and may well help explain why in a previous study, the deletion of this G gene from the same virus 257 
only marginally reduced its protective capacity (Naylor et al., 2010).  Nonetheless stop sequence 258 
differences between subtypes were not generally greater than those within subtypes, hence 259 
supported the notion of a subtype independent RG system. 260 
 261 
The above data taken as whole suggested that for an AMPV RG system subtype A and B 262 
components might be fully interchanged. This proved the case  because when subtype B 263 
components became available they proved able to be substituted for subtype A components in the 264 
RG systems – and once a fully subtype B RG had been produced, both subtype A and B full length 265 
genome copies were shown to efficiently produce virus when using either subtype A or B support 266 
proteins. This indicates that the viral polymerase of either subtype is able to attach to the leader and 267 
trailer, to recognise gene start and stop sequences, and that the key viral protein genes shared 268 
sufficient functional similarity to support rescue. It remains uncertain as to whether subtype A/B 269 
components might be able to recover a full length subtype C copy, though this could easily be tested 270 
through collaboration between groups in possession of the different RG systems.  271 
 272 
As a more practical point, the cloning of genome copies in bacterial plasmids offer considerable 273 
flexibility when compared to alternatives more able to handle difficult sequences such as cloning 274 
into bacterial artificial chromosomes or other larger viruses such as fowlpox or vaccinia. In this 275 
study the previously recognised ability of  pSMART to accept influenza virus genome segments has 276 
been extended to included the full genomes of an AMPV genome exhaustively proven very difficult 277 
to otherwise clone. It would interesting to know the limits of this approach and perhaps explore 278 
potential with larger viruses such as coronaviruses.    279 
 280 
 281 
METHODS  282 
 283 
Viruses 284 
 285 
The subtype A ( Germany A) virus used to create the first AMPV reverse genetics system was 286 
isolated in Germany in the 1990’s (Naylor et al., 2004) and was later tested in vaccination studies 287 
(Naylor et al., 2010). Other subtype A field viruses sequenced for gene sequence comparison were 288 
#8544(Jones et al., 1986), Italy 259 (Cecchinato et al., 2010), UK 3B (Mcdougall & Cook, 1986), 289 
CVL 14-1 (Collins & Gough, 1988) and UK CP/1 (Jones et al., 1991);  and commercial live 290 
vaccines Poulvac TRT, Nobilis TRT and Turkadin (discontinued).  291 
 292 
The subtype B virus used to create the first AMPV subtype B reverse genetics system was a vaccine 293 
strain derived from UK strain 11/94. Subtype B field viruses sequenced for gene sequence 294 
comparison were Italy 205 and 240 (Cecchinato et al., 2010), France 147 and 38  (Cook et al., 295 
1993), Netherlands 27 (Cook et al., 1993), Italy 16-91(Cook et al., 1993); and commercial live 296 
vaccines Nemovac, Aviffa and Nobilis Rhino CV. 297 
  298 
Determination of leader and trailer sequences 299 
 300 
Leader and trailer sequences were determined by 3’RACE on the genome and antigenome 301 
respectively using a previously described method (Brown et al., 2013). Viruses sequenced were 302 
#8544, Poulvac TRT, Italy 240, RhinoCV and Nemovac. Subsequently leader and trailer sequences 303 
of recombinant rescued viruses (recombinants of Germany A, Fort Dodge vaccine, Rhino CV) were 304 
determined.  305 
 306 
Determination of 3’ termini sequence of  subtype A and B AMPV mRNAs 307 
 308 
Virus messages were amplified by RT-PCR using the technique previously described in our 309 
laboratory (Brown et al., 2011).  Briefly RT was performed with a primer containing 20 Ts 310 
followed by an adaptor sequence at its 5’ terminus. This was amplified by PCR using 2 primers, one 311 
within in the respective genes and one matching the adaptor. These PCR products were sequenced 312 
towards the polyA tail using the same gene specific primers. 313 
 314 
Determination of viral gene sequences and their comparison. 315 
 316 
Sequences of subtype A and B virus genes were determined by sequencing of PCR amplified 317 
genome sections, as described in previous studies (Brown et al., 2011; Cecchinato et al., 2010; 318 
Naylor et al., 2004; Naylor et al., 2007). Using Bioedit, nucleotide sequences aligned and inter-319 
subtype identities calculated, then sequences were translated to allow predicted amino acid 320 
identities and similarities to be calculated. 321 
 322 
 323 
Construction of subtype B reverse genetics system 324 
 325 
Subtype B support protein genes N, P, M2 were cloned into the same plasmids as had been used 326 
previously in the subtype A rescue system (Naylor et al., 2004).   327 
 328 
To construct the subtype B genome copy, sections were amplified by high fidelity RT-PCR using 329 
primers introducing Xho1/Sal 1 RE sites at positions shown in Figure 3.  The approach was 330 
essentially that previously employed  in constructing our subtype A reverse genetics system (Naylor 331 
et al., 2004).  Because of previous stability issue of copied DNA in cloning bacteria, sections were 332 
sequentially cloned into the pSMART LC Kan  ( Lucigen) as shown in Fig 3 to produce a full 333 
length genome copy preceded by the T7 promoter and followed by the Hepatitis delta virus 334 
ribozyme (HDVR).  335 
 336 
For the L gene, because of cloning stability issues with the original plasmid used to clone the 337 
subtype A L, it was copied by hi-fidelity PCR from the cloned full subtype B genome to include the 338 
pSMART LC Kan sequence . This was ligated and cloned.   339 
 340 
Recovery of viruses  341 
 342 
Vero cells infected with a fowlpox recombinant virus expressing T7 polymerase were transfected 343 
initially with a cloned subtype A genome, together with subtype A support protein genes, and 344 
cloned subtype B support protein genes as they became available, using Lipofectamine 2000, under  345 
the same conditions and concentrations previously used for subtype A rescue (Naylor et al., 2004). 346 
Subsequently the cloned subtype B genome replaced the subtype A genome. Eventually subtype B 347 
components entirely replaced those from subtype A. In addition a subtype B genome copy was used 348 
with only subtype A components. Details are given in Table 5. 349 
 350 
  351 
 352 
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Table 1  
 
Determined leader and trailer sequences for subtype A and B viruses, with published subtype C for 
reference 
 
 
 
AMPV 
subtype 
Leader and complimented trailer sequences  
for subtype A, B and C viruses 
  A leader 3’UGCUCUUUUUUUGCAUAAAUUCGUC…………N start 5’ 
  A trailer1  3’UGCUCUUUUUUUUGGCAUAAGUAGU…………L stop 5’ 
 
B Lead 3’UGCUCUUUUUUUGCGUAAGUUCAG…………N start 5’ 
  B trailer1 3’UGCCGUUUUUUUGGCAUAAGUUAU…………L stop 5’ 
 
2C leader 3’UGCUCUUUUUUUGCGUAUAUUCUG…………N start 5’ 
2C trailer1 3’UGCCGUUUUUUUGGCAUAAGUAGG…………L stop 5’ 
 
1 antigenome sequence 
2 Not determined by the authors and based on accession AY579780 
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Table 2 
 
Transcription start sequences and determined transcription stops for subtype A and B viruses  
 
 
Gene AMPV 
subtype 
Sequence from transcription start to subsequent transcription start 
 
N  
A CCCUGUUCAGUUUU -ORF+NCGE- UCA UUAA2UUUUUUUAUA 
B CCCUGUUCAUUUU  -ORF+NCGE- UCA UUAA2UUUUUAAG  
C1 CCCUGUUCACUUU  -ORF+NCGE- UCA UUAAUUUUUUUAUA 
 
P  
A CCCUGUUCAUUGU  -ORF+NCGE- UCA AUAC2UUUUUUA 
B CCCUGUUCACUUU  -ORF+NCGE- UCA AUAC2UUUUUUA 
C1 CCCUGUUCAGUUU  -ORF+NCGE-  UCA AUUAUUUUUUG 
 
M  
A CCCUGUUCAGUUU  -ORF+NCGE- UCA GUUA2UUUUUUAA 
B CCCUGUUCAUUUG  -ORF+NCGE- UCA AAUUA2UUUUUUAUA 
C1 CCCUGUUCACCUU  -ORF+NCGE- UCA GUUCUAUUUGUGUCUCUCAUGUGAAUGGUUUAGUGUCAUU 
GUUAAAGCAAAAAUUGGGAGAGUAUCAAUAAUGGAUCGAACUAUAAUAAAUCUUUUUUAA 
 
F 
A CCCUGUUCAUCC   -ORF+NCGE- UCA AUAAA2UUUUAA 
B CCCCGUUCAUUU   -ORF+NCGE- UCA AUGUA2UUUUUUCA 
C CCCUGUUCACUUU  -ORF+NCGE- UCA AUGAUUUUUUAA 
 
M2 
A CCCUGUUCACUUC  -ORF+NCGE- UCA AUUAA 2UUUUGGUUAAUUCGAUAUUCAGGUUUUUUCCCA 
B CCCUGUUCAUUUC  -ORF+NCGE- UCA AUAUA2UUUUUGUUAACUCGUGGGGGGGGCUUUUUUCUA 
C1 CCCUGUUCACUUC  -ORF+NCGE- UCA AUUAUUUUUUAA 
 
SH 
A CCCUGUUCAGUAU  -ORF+NCGE- UCA UAAUAAAUUAA2UUUUUCUUUCCAG  
Germany A CCCUGUUCAGUAU  -ORF+NCGE- UCA UAAUAAAUAAAUGUUUCUUUCCAG did not stop 
B CCCCGUUCAGUUC  -ORF+NCGE- UCA AUUAA2UUUUAGUCUUCUG 
C1 CCCUGUUCAGUUG  -ORF+NCGE- UCA AUAAAUUUUUAGUACUUAUACAGACCUGUCACGGUUCCGGUUC 
UUUUUGGUUGUGCUCUUGUCCACUAGGUUACUAAUUUUUGCUAGUCUCUUCCUUUUUG 
 
G 
A CCCUGUUCAUAGAGU-ORF+NCGE- UCA AUUGA2UUUUUACUUGUGUAUAUAUAGACUAUUAUUUUU 
UUGUGUAGUCUAUCAGAUUUUGUUAAUUUUCUUACUUUUGU 
B CCCUGUUCAUAGGUC-ORF+NCGE- UCA GUUA2UUUUUCAUUGGAAAGUGUAGAUUUUAUUUCGUUUU 
UCUUCUUUUUUCUUCUUUCUUCCUUUCUUUCUUCUUCUUAUCGUGUGUUGUCUUUCCU 
C1 CCCUGUUCAGUUG  -ORF+NCGE- UCA AUUAAUUUUUCUU 
 
L 
A UCCUGGUUA      -ORF+NCGE- UCA AUUA2UUUUU to Trailer  
B CCCUGGUUA      -ORF+NCGE- UCA AUA2UUUUUU to Trailer  
C1 CCUGGUUCA      -ORF+NCGE- UCA AUAAAUUUUU to Trailer 
 
NCGE – non coding gene end 
1 Not determined by the authors and based on accession AY579780 
2 demonstrated start of polyadenylation in resulting mRNA  
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Table 3  
 
Determined Consensus gene stop signals for subtype A and B viruses, with predicted subtype C 
sequences based on database reference.   
 
 
 
 
 Subtype A Subtype B Subtype C3 
Nucleotide position   A C G U  A C G U  A C G U  
1st 0 0 0 81 U2 0 0 0 8 U 0 0 0 8 U 
2nd 0 8 0 0 C 0 8 0 0 C 0 8 0 0 C 
3rd 8 0 0 0 A 8 0 0 0 A 8 0 0 0 A 
4th 5 1 0 2 A 6 0 1 1 A 6 0 1 1 A 
5th 1 0 0 7 U 1 0 0 7 U 0 0 0 8 U 
6th 4 0 0 4 A/U 4 0 1 3 A 3 0 1 4 U 
7th 5 1 1 1 A 3 1 0 4 U 7 1 0 0 A 
8th 4 0 0 4 A/U 4 0 0 4 A/U 3 0 0 5 U 
9th 1 0 0 7 U 0 0 0 8 U 1 0 0 7 U 
10th 1 0 0 7 U 0 0 0 8 U 0 0 0 8 U 
11th 0 0 0 8 U 0 0 0 8 U 0 0 0 8 U 
12th 1 0 0 7 U 0 0 0 8 U 0 0 0 8 U 
 
 
1 Black shading identifies the majority nucleotide at the given position within the eight gene stop signals  
2 Grey shading denotes the consensus stop signal for the given subtype   
3 Not determined by the authors and based on accession AY579780 
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Table 4 
 
Nucleotide identities, and  predicted amino acid identities and similarities, comparing AMPV 
subtypes A, B and C. 
 
 
 
 
Gene  Subtype A vs B Subtype A vs C  Subtype B vs C 
Nuc aa nuc aa nuc aa 
N 761 912 973 66 70 87 68 71 87 
P 70 72 88 58 53 69 59 53 69 
M 75 90 98 70 78 91 72 78 91 
F 74 83 91 69 72 85 67 72 86 
M2 78 89 96 64 71 88 65 73 86 
SH 60 50 60 40 20 31 43 19 34 
G 53 36 46 28 10 17 29 12 20 
L 74 86 94 46 64 79 46 64 79 
 
Shading denotes greater than 80% identity/similarity 
 
1 nucleotide identity 
2 amino acid identity 
3 amino acid similarity 
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Table 5 
 
Combinations of RG components used in virus rescue attempts 
 
 
 
 
Rescue 
attempt  
Subtype B  
components 
Subtype A  
components 
Outcome 
1 N 
 
P 
M2 
L 
genome 
Virus 
recovered  
2 N 
P 
M2 
L 
genome 
Virus 
recovered 
 N 
P 
M2 
L 
genome 
Virus 
recovered 
3 N 
P 
M2 
genome 
L Virus 
recovered  
4 N 
P 
M2 
L  
genome 
 Virus 
recovered 
5 N 
P 
M2 
L 
 genome Virus 
recovered 
6 genome N 
P 
M2 
L 
Virus 
recovered 
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1 polyadenylated DNA copies of genomic sense leader
2 polyadenylated DNA copies of antigenome sense trailer
3Subtype A 3Subtype B
Leader 1
Trailer 2
3’5’
3’5’
3’
3’5’
5’
3Sequence common for all viruses of this subtype
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Figure 2
2
1 Common terminal sequence found in all viruses sequenced except for subtype A, SH gene
2 No monocistronic SH mRNA. Sequence displayed shows the region of discistronic SH-G mRNA 
Underlined sequences are common between all viruses sequenced except subtype A, SH gene
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